The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Anand, P., Nair, H. B., Sung, B., Kunnumakkara, A. B., Yadav, V. R., Tekmal, R. R., & Aggarwal, B. B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.003 · Cited by 574
RetractedMatsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Luminescent quantum dots for multiplexed biological detection and imaging
Chan, W. C. W., Maxwell, D. J., Gao, X., Bailey, R. E., Han, M., & Nie, S. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00282-3 · Cited by 2,068
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Mahmoudi, M., Sant, S., Wang, B., Laurent, S., & Sen, T. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.05.006 · Cited by 1,881
Aggarwal, B. B., & Harikumar, K. B. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 1,716
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Biological Responses to Materials
Anderson, J. M. (2001) · Annual Review of Materials Research · doi:10.1146/annurev.matsci.31.1.81 · Cited by 1,465
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationPapapetropoulos, A., García-Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119868 · Cited by 1,191
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Self-citationMultidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 990
Self-citationShaikh, J., Ankola, D. D., Beniwal, V., Singh, D., & Kumar, M. N. V. R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.019 · Cited by 956
Biotransformation of Curcumin Through Reduction and Glucuronidation in Mice
Pan, M.-H., Huang, T.-M., & Lin, J.-K. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15211-7 · Cited by 946
The present and future of nanotechnology in human health care
Sahoo, S. K., Parveen, S., & Panda, J. J. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.11.008 · Cited by 905
Self-citationCurrent advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Biodegradable polymers as drug delivery systems
(1992) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(92)90663-b · Cited by 779
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Nanotechnology-based drug delivery systems
Suri, S. S., Fenniri, H., & Singh, B. (2007) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-2-16 · Cited by 755
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 700
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Bilati, U., Allémann, E., & Doelker, E. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.09.011 · Cited by 686
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Lübbe, A. S., Bergemann, C., Riess, H. B., Schriever, F., Reichardt, P., Possinger, K., Matthias, M., Dörken, B., Herrmann, F., Gürtler, R., et al. (1996) · PubMed · Cited by 652
DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts
Giovanella, B. C., Stehlin, J. S., Wall, M. E., Wani, M. C., Nicholas, A. W., Liu, L. F., Silber, R., & Potmesil, M. (1989) · Science · doi:10.1126/science.2555920 · Cited by 650
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Polymer Architecture and Drug Delivery
Qiu, L. Y., & Bae, Y. H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9046-2 · Cited by 604
Encyclopedic handbook of biomaterials and bioengineering
Wise, D. L. (1995) · Cited by 584
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
Hidalgo, M., & Rowinsky, E. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204091 · Cited by 582
Yallapu, M. M., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.05.022 · Cited by 579
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles
Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00315-0 · Cited by 553
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
Pommier, Y., Pourquier, P., Fan, Y., & Strumberg, D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00129-8 · Cited by 551
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Gardner, T. W., Antonetti, D. A., Barber, A. J., LaNoue, K. F., & Levison, S. W. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00387-9 · Cited by 535
Nano and microparticles as controlled drug delivery devices.
Kumar, M. N. R. (2000) · PubMed · Cited by 534
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
Xing, Y., Chaudry, Q., Shen, C., Kong, K. Y., Zhau, H. E., Chung, L. W., Petros, J. A., O'Regan, R. M., Yezhelyev, M. V., Simons, J. W., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.107 · Cited by 528
Brannon-Peppas, L. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00324-x · Cited by 528
Charles F. Kettring prize. Fundamental studies with cisplatin
Rosenberg, B. (1985) · Cancer · doi:10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l · Cited by 517
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Self-citationAvgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
PHARMACOKINETICS AND PHARMACODYNAMICS OF CURCUMIN
Sharma, R. A., Steward, W. P., & Gescher, A. J. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_20 · Cited by 476
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Chan, S., Scheulen, M. E., Johnston, S., Mross, K., Cardoso, F., Dittrich, C., Eiermann, W., Hess, D., Morant, R., Semiglazov, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.66.130 · Cited by 468
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee, A., & Vishwanatha, J. K. (2009) · PubMed · Cited by 444
Polymer conjugates: nanosized medicines for treating cancer
Vicent, M. J., & Duncan, R. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.11.006 · Cited by 443
Advances in fluorescence imaging with quantum dot bio-probes
Pinaud, F., Michalet, X., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Iyer, G., & Weiss, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.018 · Cited by 441
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
Stroh, M., Zimmer, J. P., Duda, D. G., Levchenko, T. S., Cohen, K. S., Brown, E. B., Scadden, D. T., Torchilin, V. P., Bawendi, M. G., Fukumura, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1247 · Cited by 432
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Self-citationNanosystems in Drug Targeting: Opportunities and Challenges
Vasir, J. K., Reddy, M. K., & Labhasetwar, V. D. (2005) · Current Nanoscience · doi:10.2174/1573413052953110 · Cited by 414
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
Lübbe, A. S., Bergemann, C., Huhnt, W., Fricke, T., Riess, H. B., Brock, J., & Huhn, D. (1996) · PubMed · Cited by 397
Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy
Dilnawaz, F., Singh, A., Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.057 · Cited by 385
Self-citationIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates
Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00280-7 · Cited by 374
Controlled release of bioactive agents from lactide/glycolide polymers
Lewis, D. H. (1990) · Drugs and the pharmaceutical sciences · Cited by 370
Nanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Multifunctional Nanoparticles for Combined Doxorubicin and Photothermal Treatments
Park, H., Yang, J., Lee, J., Haam, S., Choi, I.-H., & Yoo, K.-H. (2009) · ACS Nano · doi:10.1021/nn900215k · Cited by 359
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
van Vlerken, L. E., & Amiji, M. M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.205 · Cited by 352
Sahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Self-citationTargeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Self-citationSahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Self-citationPatil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311
Panyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Self-citationGelperina, S., Maksimenko, O., Khalansky, A., Vanchugova, L., Shipulo, E., Abbasova, K., Berdiev, R., Wohlfart, S., Chepurnova, N., & Kreuter, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.003 · Cited by 293
Stolnik, S., Dunn, S. E., Garnett, M. C., Davies, M. C., Coombes, A. G. A., Taylor, D. C., Irving, M. P., Purkiss, S. C., Tadros, T. F., Davis, S. S., et al. (1994) · Pharmaceutical Research · doi:10.1023/a:1018931820564 · Cited by 292
Determinants of Rapamycin Sensitivity in Breast Cancer Cells
Noh, W.-C., Mondesire, W. H., Peng, J., Jian, W., Zhang, H., Dong, J., Mills, G. B., Hung, M.-C., & Meric-Bernstam, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0043 · Cited by 285
Nanoparticle‐Mediated Drug Delivery and Gene Therapy
Jin, S., & Ye, K. (2007) · Biotechnology Progress · doi:10.1021/bp060348j · Cited by 283
Song, X., Zhao, Y., Wu, W., Bi, Y., Cai, Z., Chen, Q., Li, Y., & Hou, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.034 · Cited by 282
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles
GOMEZGAETE, C., TSAPIS, N., BESNARD, M., BOCHOT, A., & FATTAL, E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.028 · Cited by 259
Targeted Delivery of Multifunctional Magnetic Nanoparticles
McCarthy, J. R., Kelly, K. A., Sun, E. Y., & Weissleder, R. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.153 · Cited by 255
Betancourt, T., Brown, B., & Brannon-Peppas, L. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.219 · Cited by 249
Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9763-4 · Cited by 246
Preclinical Pharmacology of the Taxanes: Implications of the Differences
Gligorov, J., & Lotz, J. P. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_2-3 · Cited by 244
Yazawa, K., Fujimori, M., Amano, J., Kano, Y., & Taniguchi, S. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700122 · Cited by 241
Konno, T., Maeda, H., Iwai, K., Maki, S., Tashiro, S., Uchida, M., & Miyauchi, Y. (1984) · Cancer · doi:10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f · Cited by 233
Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis
Patil, S. D., Papadmitrakopoulos, F., & Burgess, D. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.013 · Cited by 230
Advances of Cancer Therapy by Nanotechnology
Wang, X., Wang, Y., Chen, Z. G., & Shin, D. M. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.1.1 · Cited by 230
Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release
Yoo, H. S., Oh, J. E., Lee, K. H., & Park, T. G. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908421434 · Cited by 225
Maeda, H., Noguchi, Y., Sato, K., & Akaike, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02362.x · Cited by 221
Emerging application of quantum dots for drug delivery and therapy
Qi, L., & Gao, X. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.3.263 · Cited by 220
Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Misra, R., & Sahoo, S. K. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.010 · Cited by 219
Self-citationSynthesis of Pegylated Immunonanoparticles
Olivier, J.-C., Huertas, R., Lee, H. J., Calon, F., & Pardridge, W. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1019842024814 · Cited by 217
Wu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Simamora, P., Alvarez, J. M., & Yalkowsky, S. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00617-7 · Cited by 211
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Bazile, D. V., Ropert, C., Huve, P., Verrecchia, T., Mariard, M., Frydman, A., Veillard, M., & Spenlehauer, G. (1992) · Biomaterials · doi:10.1016/0142-9612(92)90142-b · Cited by 200
Panyam, J., & Labhasetwar, V. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034002c · Cited by 195
Nanomedicine: Clinical Applications of Polyethylene Glycol Conjugated Proteins and Drugs
Parveen, S., & Sahoo, S. K. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00002 · Cited by 189
Self-citationBlum, J. L., Savin, M. A., Edelman, G., Pippen, J. E., Robert, N. J., Geister, B. V., Kirby, R. L., Clawson, A., & O'Shaughnessy, J. A. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.n.049 · Cited by 172
In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors
Koziara, J. M., Whisman, T. R., Tseng, M. T., & Mumper, R. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.001 · Cited by 158
Bhardwaj, V., Ankola, D. D., Gupta, S., Schneider, M., Lehr, C., & Kumar, M. N. V. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9965-4 · Cited by 145
Butoescu, N., Seemayer, C. A., Foti, M., Jordan, O., & Doelker, É. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.017 · Cited by 144
Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes
Cheng, F., Wang, S. P.-H., Su, C.-H., Tsai, T.-L., Wu, P., Shieh, D.-B., Chen, J., Hsieh, P. C. H., & Yeh, C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.010 · Cited by 142
Bilati, U., Allémann, É., & Doelker, É. (2005) · Journal of Microencapsulation · doi:10.1080/02652040400026442 · Cited by 140
Chumakova, O. V., Liopo, A. V., Андреев, В. Г., Cicenaite, I., Evers, B. M., Chakrabarty, S., Pappas, T. C., & Esenaliev, R. O. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.023 · Cited by 136
Reddy, L. H., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. R. (2004) · The AAPS Journal · doi:10.1208/aapsj060323 · Cited by 135
Ong, B. Y. S., Ranganath, S. H., Lee, L. Y., Fan, L., Lee, H. S., Sahinidis, N. V., & Wang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.030 · Cited by 132
Conway, M. A., Madrigal-Estebas, L., McClean, S., Brayden, D. J., & Mills, K. H. G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00433-3 · Cited by 130
Prabha, S., & Labhasetwar, V. D. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049970+ · Cited by 128
Injectable Sustained Release Microparticles of Curcumin: A New Concept for Cancer Chemoprevention
Shahani, K., Swaminathan, S. K., Freeman, D. J., Blum, A. P., Ma, L., & Panyam, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4362 · Cited by 128
Dhanikula, A. B., & Panchagnula, R. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00087-3 · Cited by 126
Bissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Wang, Y., Ng, Y. W., Chen, Y., Shuter, B., Yi, J., Ding, J., Wang, S., & Feng, S. (2008) · Advanced Functional Materials · doi:10.1002/adfm.200700456 · Cited by 123
Pharmacogenetics of paclitaxel metabolism
Spratlin, J. L., & Sawyer, M. B. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.09.006 · Cited by 123
Muggia, F. M. (1999) · PubMed · Cited by 122
Jung, T., Breitenbach, A., & Kissel, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00201-7 · Cited by 120
Ranganath, S. H., Kee, I. H. C., Krantz, W. B., Chow, P. K. H., & Wang, C.-H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9922-2 · Cited by 113
Pharmaceutical Excipient Development: The Need for Preclinical Guidance
Baldrick, P. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1421 · Cited by 112
Zhao, L., & Feng, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22113 · Cited by 109
Boddy, A. V., Plummer, E. R., Todd, R., Sludden, J., Griffin, M., Robson, L., Cassidy, J., Bissett, D., Bernareggi, A., Verrill, M. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0803 · Cited by 108
Heyns, C. F., Simonin, M.-P., Grosgurin, P., et al. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04308.x · Cited by 104
Snehalatha, M., Kolachina, V., Saha, R. N., Babbar, A. K., & Sharma, R. K. (2008) · Drug Delivery · doi:10.1080/10717540802006500 · Cited by 102
Xie, J., & Wang, C. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7782-y · Cited by 99
Mattheolabakis, G., Taoufik, E., Haralambous, S., Roberts, M. L., & Avgoustakis, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.011 · Cited by 98
Cytotoxicity of Paclitaxel Incorporated in PLGA Nanoparticles on Hypoxic Human Tumor Cells
Jin, C. S., Bai, L., Wu, H., Song, W., Guo, G., & Dou, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9889-z · Cited by 95
Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells
Haddadi, A., Elamanchili, P., Lavasanifar, A., Das, S., Shapiro, J., & Samuel, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31373 · Cited by 90
Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice
Moreno, D., Zalba, S., Navarro-Blasco, Í., de Ilarduya, C. T., & Garrido, M. J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.005 · Cited by 90
Cui, W., Bei, J., Wang, S., Zhi, G., Zhao, Y., Zhou, X., Zhang, H., & Xu, Y. (2005) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.30189 · Cited by 89
Takashima, Y., SAITO, R., Nakajima, A., ODA, M., KIMURA, A., Kanazawa, T., & OKADA, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.042 · Cited by 86
Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs
Brown, R. E., & Links, M. J. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499001099x · Cited by 85
The contributions of Paul Ehrlich to infectious disease
Gensini, G. F., Conti, A. A., & Lippi, D. (2006) · Journal of Infection · doi:10.1016/j.jinf.2004.05.022 · Cited by 82
Zou, W., Liu, C., Chen, Z., & Zhang, N. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.016 · Cited by 75
A comparison of anionic nanoparticles and microparticles as vaccine delivery systems
Wendorf, J. R., Chesko, J., Kazzaz, J., Ugozzoli, M., Vajdy, M., O’Hagan, D. T., & Singh, M. (2008) · Human Vaccines · doi:10.4161/hv.4.1.4886 · Cited by 75
Chemotherapy for advanced ovarian cancer: overview of randomized trials.
Thigpen, J. T. (2000) · PubMed · Cited by 73
Cegnar, M., Premzl, A., Zavašnik‐Bergant, V., Kristl, J., & Kos, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.021 · Cited by 72
Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent
Wheatley, M. A., Forsberg, F., Oum, K. L., et al. (2006) · Ultrasonics · doi:10.1016/j.ultras.2006.04.003 · Cited by 71
Konno, T. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80063-2 · Cited by 69
Miura, H., Onishi, H., Sasatsu, M., & Machida, Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.009 · Cited by 61
Evaluation of PLGA Microspheres as Delivery System for Antitumor Agent-Camptothecin
Tong, W., Wang, L., & D’Souza, M. J. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120021774 · Cited by 59
New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles
Zou, W., Cao, G., Xi, Y., & Zhang, N. (2009) · Drug Delivery · doi:10.1080/10717540802481307 · Cited by 59
Oda, T., & Maeda, H. (1987) · PubMed · Cited by 54
Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases
Baratchi, S., Kanwar, R. K., Khoshmanesh, K., Punj, V., Chauhan, A., Matta, H., Parratt, A. J., Krishnakumar, S., Sun, X., Sahoo, S. K., et al. (2009) · Current Nanoscience · doi:10.2174/157341309787314665 · Cited by 50
Self-citationTargeting cancer cells by exploiting their resistance
Blagosklonny, M. V. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00111-4 · Cited by 50
Fischer, S., Foerg, C., Ellenberger, S., Merkle, H. P., & Gander, B. A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.015 · Cited by 50
Fluconazole encapsulation in PLGA microspheres by spray-drying
Rivera, P. A., Martínez-Ohárriz, M. C., Rubio, M. F., Irache, J. M., & Espuelas, S. (2004) · Journal of Microencapsulation · doi:10.1080/02652040310001637811 · Cited by 44
HLA-B27 and disease pathogenesis: new structural and functional insights
Bowness, P., Zaccai, N. R., Bird, L., & Jones, E. Y. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499001118 · Cited by 41
Ishitobi, M., Shin, E., & Kikkawa, N. (2001) · International Journal of Clinical Oncology · doi:10.1007/pl00012081 · Cited by 38
Miyamoto, Y., Oda, T., & Maeda, H. (1990) · PubMed · Cited by 37
Guo, G., Liu, W., Liang, J., Xu, H., He, Z., & Yang, X. (2006) · Materials Letters · doi:10.1016/j.matlet.2006.01.073 · Cited by 36
Dadashzadeh, S., Derakhshandeh, K., & Shirazi, F. H. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283099e5c · Cited by 34
Colloidal quantum dots initiating current bursts in lipid bilayers
Ramachandran, S., Merrill, N. E., Blick, R. H., et al. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.08.042 · Cited by 29
Richards, D., Richards, P. D., Bodkin, D., Neubauer, M., & Oldham, F. B. (2005) · Clinical Lung Cancer · doi:10.3816/clc.2005.n.039 · Cited by 28
Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact
Gerolami, R., Uch, R., Bréchot, C., Mannoni, P., & Bagnis, C. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700610 · Cited by 26
Kuo, W., Ku, Y., Sei, H., Cheng, F., & Yeh, C. (2009) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.200900136 · Cited by 16
Kuo, W., Hwang, S., Sei, H., Ku, Y., Hsu, L., Cheng, F., Hsieh, P. C. H., & Yeh, C. (2009) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.200900138 · Cited by 7
(1989) · PubMed
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin, & Arora (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,117
Metadata
- Authors
- Acharya, S., & Sahoo, S. K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 63
- Issue
- 3
- Pages
- 170-183
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2003474213
- Cited by
- 1,112
- References
- 171
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.